CA1042915A - 2-iminomethyl-3',4',5'-trimethoxycinnamic acids and esters thereof, and their production - Google Patents

2-iminomethyl-3',4',5'-trimethoxycinnamic acids and esters thereof, and their production

Info

Publication number
CA1042915A
CA1042915A CA208,720A CA208720A CA1042915A CA 1042915 A CA1042915 A CA 1042915A CA 208720 A CA208720 A CA 208720A CA 1042915 A CA1042915 A CA 1042915A
Authority
CA
Canada
Prior art keywords
formula
grams
iminomethyl
trimethoxycinnamic
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA208,720A
Other languages
French (fr)
Other versions
CA208720S (en
Inventor
Borge Alhede
Niels Gelting
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hexal AS
Original Assignee
Gea AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gea AS filed Critical Gea AS
Application granted granted Critical
Publication of CA1042915A publication Critical patent/CA1042915A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • C07D239/49Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50Three nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

ABSTRACT OF THE DISCLOSURE
2-Iminomethyl-3',4',5'-trimethoxycinnamic acids and lower alkyl esters thereof are produced by reducing 3,4,5-tri-methoxybenzylidene cyanoacetic acid, or the corresponding ester thereof, in neutral or alkaline medium preferably in a pyridine base as solvent.

Description

Z9~5 This invention relates to 2-iminomethyl-3',4',5'-tri-me-thoxycinnamic acid and esters thereof having the formula CH O
~ COOR
~ I ,, 3 ~ ~ CH = C
\ CH = NH
wherein R is a hydrogen atom or an alkyl group having 1-4 carbon atoms, being useful as intermediates in the produc-tion of 2,4-diamino-5-(3',4',5'-trimethoxybenzyl)-pyrimi-dine. The latter is a known compound, also called trimetho- i prim, and has the formula CH~O

3 ~ CH2 ~ ~ 2 Trimethoprim shows a useful antibacterial and sulphon-amide-potentiating effect.
lo The inven-tion also relates to a process for the pro-duction of the compounds of formula I.
It is known that the ethyl ester of 3,4,5-trimethoxy-benzylidene-cyanoacetic acid having the formula CH O
~ . COOC2H5 3 ~ CH = IC III
~ ..
CN
~ CH30 can be reduced in acid medium to form 3,4,5-trimethoxybenzyl-cyanoacetic acid ethyl ester having the formula CH O
,~ COOC2H5 ; 3 ~~ CH2 - CH IV
.\ CN

-L04~
as a colourless oil, and that the said compound can be con-densed with guanidine to form 2,4-diamino-6-hydroxy-5-(3', ; 4',5'-trimethoxybenzyl)-pyrimidine having the formula CH~0. ~ CH2 ~ ~ ~ 2 which again can be converted into trimethoprim by removal of the 6-hydroxy group.
The said known method is disadvantageous in that re-duction of the compound of formula III yields a compound, formula IV 9 which owing to its physical properties is only very difficultly recovered in an even tolerably pure s-tate.
lo This means that the compound of ~ormula V, which is produced by condensation wi-th guanidine, and/or the trimethoprim pro-duced therefrom, has to be subjected to further cost-adding purifications in order to get a pharmaceutically acceptable product The object of the present invention is to overcome the said disadvantage by providing an intermediate suitable ~or the production o~ trimethoprim, which is easily recovered in a pure state by crystallisation, instead of the compound of formula IV.
It has surprisingly been found that this is possible, when using, as an intermediate in the production of trime-thoprim, hitherto unknown 2-iminomethyl-3',4',5'-trime-th-oxycinnamic acid compounds which according to the inven-tion are characterized in having the formula I, wherein R
is a hydrogen atom or an alkyl group having 1-4 c~rbon atoms.
According to the invention, the compounds of ~ormula I
can be produced under mild conditions, at room temperature, . . . ......

~L~4Z9~5 by reduction in a neutral or alkaline medium of 3,4,5-trimethoxy-benzylidene-cyanoacetic acid or an ester thereof of the formula CH30 ~/ r CH =f II

CN

wherein R is a hydrogen atom or an alkyl group having 1-4 carbon atoms. The resulting compound of formula I can be isolated in crystalline form, and it is recovered in quantitative yield. It is thus extremely pure and will give extremely pure products when used as an intermediate in the production of trimethoprim.
The reduction of the compound of formula II may be carried out in any suitable solvent, such as ethanol, but according to the invention particularly good results are obtained by using pyridine bases, preferably picoline, as a solvent.
Trimethoprim can be produced from the present compounds of formula I by first condensing with guanidine to obtain the formerly mentioned 2.4-diamino-6-hydroxy-5-~3',4',5'-trimethoxy-benzyl)-pyrimidine of formula V, which in known manner is converted into trimethoprim by removing the 6-hydroxy group.
In the following the production and use of the present intermediates is illustrated by some Examples.
Example 1
2-Iminomethyl-3',4',5'--trimethoxycinnamic acid ethyl ester .
58.2 grams (0.2 mole) of 3,4,5-trimethoxy-benzylidene-cyanoacetic acid ethyl ester and 1 gram of Pd/C ~10%) in -" ~L0~29~s 380 ml of 2-picoline were s-tirred at room temperature under a hydrogen pressure of 10 atmospheres, until no more hydro-gen was consumed, when stirring was continued for further two hours. The catalyst was filtered off, and the picoline was evaporated in va uo. The residue was dissolved in 150 ml of hot ethanol. By cooling, 58.5 grams (100%) of 2-~ino-methyl-3',4',5'-trimethoxycinnamic acid ethyl ester with melting point 48-49C crystallized.

lo Example 2 2-Iminometh~1-3',4',5'-trimethoxycinnamic acid ethyl ester 8,73 grams (0.030 mole) of 3,4,5-trimethoxy-benzylidene-cyanoacetic acid ethyl ester were dissolved in 130 ml o,f an-hydrous e-thanol. There was added 0.1 gram palladium on car-bon (10%), and the mixture was placed in a hydrogenation au-toclave. Hydrogen was supplied to a pressure of 11 atmos-pheres, and the reaction mixture was left with stirring, un-til one equivalent of hydrogen had been consumed, when the reaction stopped. Pouring out of the reaction mixture dis-closed that a white subs-tance had crystallized. The mixture was heated to 50C, resulting in the said white substance dissolvin~; the catalyst was filtered off, and 6.31 grams of the white product crystallized by cooling. Partial evapora-tion of the paren-t lye yielded further 2.29 grams, making a total yield of 8.60 grams, 97.0%. After recrystallization from anhydrous eth~nol, the compound melted at 48-49C.
Use of the intermediate in the production of trimetho-prim is illustra-ted by the following Examples.

Example 3 2,4-Diamino-6-hydrox~-5-(31,4',~5'-trimeth~ybenzyl)~ imidine 42~
To a mixture of 14.7 grams (0.050 mole) of the ethyl ester of 2-iminome-thyl-3',4l,5'-trimethoxycinnamic acid and 4.78 grams (0.050 mole) of guanidine hydrochloride in 150 ml of toluene were added 5.4 grams (0.10 mole) o~ sodium methoxide. The reaction mixture was refluxed for 11 hours.
The toluene was removed in vacuo by suction, and the resi-due was dissolved in dilute aqueous sodium hydroxide. Acetic acid was added to the solution to pH 4-6, resulting in the precipitation of an almost white product. The produc-t was lo removed by filtration, washed with water, and dried7 Yield r 13.2 grams, 86.3%.
r Example 4 a) 6-Chloro-2 4-diamino-5-(3' L4~ ,5'-trimethox;ybenz~ pyri-_idine A mixture of 15.6 grams (0.051 mole) of 2,4-diamino-6-hydroxy-5-(3',4',5'-trimethoxybenzyl)-pyrimidine and 75 mI
of phosphorus oxychloride was heated on a steam bath ~or three hours. Excess of phosphorus oxychloride was removed i in vacuo by filtration with suction. Ice was added to the residue, and potassium carbonate was added to pH 8. The pre- P
cipitated substance was filtered off, washed with water, and dried. Yield 14.1 grams~ 85.2%.
After recrystallization from nitromethane, the compound melted at 218.5-220.5C.
b) 2,4-Diamino-5-(3',4't5'-trimethoxybenzYl)-pyrimidine r ~ 8.11 grams (0.025 mole) of 6-chloro-2,4-diamino-5-(3', It `~ 4',5'-trime-thoxybenzyl)-pyrimidine were suspended in 300 ml of 96% ethanol, and 0.6 gram o~ palladium on carbon (5%) was added. Hydrogen at atmospheric pressure was supplied to the suspension. After consumption of one equivalent of hydrogen, ~ Z~L5 the reaction stopped. The reaction mixture was evaporated almost to dryness, and dilute acetic acid was added. The ca-talyst was removed by filtration. Aqueous sodium hydroxide was added to make the parent lye alkaline, whereby 2,4-dia- ;mino-5-(3',4',5'-trimethoxybenzyl)-pyrimidine precipitated.
The compound was removed by filtration, washed with water, and dried. Yield 6.59 grams, 90.9%.
After recrystallization from ethanol, the compound melted at 200.5-202.0C.
lo f Example 5 a) 6-Chloro-2,4-diamino-5-(3' 4' ~-trimethoxybe midine A mixture of 15.6 grams (0.051 mole) of 2,4-diamino-6-hydroxy-5-(3t,4',5'-trimethoxybenzyl)-pyrimidine and 75 ml of phosphorus oxychloride was heated on a steam bath for I four hours. Excess of phosphorus oxychloride was removed I in vacuo by suction. Ice was added to the residue, and po-tassium carbonate was added to pH 8. The precipitated com-pound was sucked off, washed with water, and dried. Yield 14.9 g, 90.0%. ~
b) 2,4-Diami~o-6-hydrazino-~-(3'~4' ~ l, pyrimidine 16.2 grams (0.050 mole) of 6-chloro-2,4-diamino-5-(3'-4',5'-trimethoxybenzyl)-pyrimidine were suspended in 85 ml of hydrazine hydrate. The mixture was refluxed to dissolve ~' the chlorinated compound. After an hour and a half, the reaction mixture was cooled in ice water and the hydrazino derivative crystallized. The compound was filtered from the parent lye and washed with cold methanol on the filter.
Yield 15.1 grams, 94~. Mel ing point 159-162C.

. . .

~Z~S
c) 2,4-Diam no-5-(3'~4'.5'-trimethox~benzyl)-pyrimidine s 8.0 grams (0.025 mole) of 2,4-diamino-6-hydrazino-5-(3',4',5'-trimethoxybenzyl)-pyrimidine were suspended in 100 ml of water. The mixture was heated to 100C, at which temperature 250 ml of a 0.40 M aqueous solution of CuS04 ~;
were added dropwise during 3/4 hour. After the said addition, -the mixture was cooled, and free Cu, precipitated during the reaction, was filtered off. Ammonia was added to make the parent lye alkaline, resulting in the precipitation of a lo greyish green substance, which was removed by filtration, and aqueous sodium hydroxide was added to the parent lye, whereby a further amount of the greyish green substance was precipitated and also filtered off. The two fractions of substance were recrystallized from H20 and activated carbon to yield 6.2 grams, 85.5%, of 2,4-diamino-5-(3i,4~,5'-tri-methoxybenzyl)-pyrimidine with melting point 199.5-201.5C.

~.

.

Claims (4)

THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A process for the production of 2-iminomethyl-3', 4',5'-trimethoxycinnamic acid and esters thereof of the formula I

wherein R is a hydrogen atom or an alkyl group having 1-4 carbon atoms, which comprises reducing 3,4,5-trimethoxybenzylidene-cyanoacetic acid or an ester thereof of the formula II

wherein R is as hereinbefore defined in a neutral or alkaline medium.
2. A process according to claim 1, characterized in that the reduction is carried out using a pyridine base as a solvent.
3. A process as claimed in claim 2 in which the pyridine base is picoline.
4. A process as claimed in claim 1 in which R is methyl or ethyl.
CA208,720A 1973-09-10 1974-09-09 2-iminomethyl-3',4',5'-trimethoxycinnamic acids and esters thereof, and their production Expired CA1042915A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK495973A DK495973A (en) 1973-09-10 1973-09-10

Publications (1)

Publication Number Publication Date
CA1042915A true CA1042915A (en) 1978-11-21

Family

ID=8138193

Family Applications (1)

Application Number Title Priority Date Filing Date
CA208,720A Expired CA1042915A (en) 1973-09-10 1974-09-09 2-iminomethyl-3',4',5'-trimethoxycinnamic acids and esters thereof, and their production

Country Status (9)

Country Link
JP (1) JPS5076042A (en)
AT (1) AT336581B (en)
CA (1) CA1042915A (en)
DE (1) DE2443079A1 (en)
DK (1) DK495973A (en)
GB (1) GB1442477A (en)
HK (1) HK12478A (en)
KE (1) KE2806A (en)
NL (1) NL7411932A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4918716B2 (en) * 2005-08-03 2012-04-18 セイコーインスツル株式会社 Hydrogen generation facility and fuel cell system

Also Published As

Publication number Publication date
JPS5076042A (en) 1975-06-21
NL7411932A (en) 1975-03-12
DE2443079A1 (en) 1975-03-20
AT336581B (en) 1977-05-10
KE2806A (en) 1978-02-17
ATA724374A (en) 1976-09-15
HK12478A (en) 1978-03-10
DK495973A (en) 1975-05-12
GB1442477A (en) 1976-07-14

Similar Documents

Publication Publication Date Title
US2581889A (en) Method of preparing pyrimidopyrazines
Gowenlock et al. 167. Syntheses of 2-monosubstituted and 2: 3-disubstituted quinoxalines
RU2158266C2 (en) Method of preparing purine compounds, intermediate compounds used therein, and method of preparation thereof
US3859287A (en) Thiopteridines and process for producing same
CA1042915A (en) 2-iminomethyl-3',4',5'-trimethoxycinnamic acids and esters thereof, and their production
US5162584A (en) Fluorobenzene derivatives
US3960856A (en) Process for the preparation of 4-hydroxy-3-(5-methyl-3-isoxazolylcarbamoyl)-2-methyl-2H-1,2-benzothiazine 1,1-dioxide
Taylor et al. Pteridines. V. Deamination studies on certain aminopteridines
HU196395B (en) Process for decyanization of 8-/hydroxi-methil/-d-ergolin-6-carbonitril
US2561323A (en) Method of preparing glutamic acid mono esters
US4567261A (en) Preparation of riboflavin
US5405987A (en) Process for preparing pyridine and quinoline derivatives
US4985563A (en) Process for the preparation of 6-piperidino-2,4-diamino pyrimidine-3-oxide
US4841092A (en) Preparation of tris(2-cyanoethyl)amine
SU1498390A3 (en) Method of producing 6-amino-1,2-dihydro-1-oxy-2-imino-4-piperidinpyrimedine
KR970005910B1 (en) Process for the preparation of quinoline carboxylic acids
US4440928A (en) Process for preparation of uracils
US4476306A (en) Method of preparing 2,4-dihydroxypyrimidine
US4423219A (en) Production of purine derivatives and intermediates therefor
US4137411A (en) Preparation of 2,4-diamino-5-(4-amino-3,5-substituted-benzyl)-pyrimidines
CA1167844A (en) Method for preparing n-¬4-¬¬(2,4-diamino-6- pteridinyl)- methyl|methylamino|benzoyl|glutamic acid
US4024136A (en) Process for the preparation of 4-hydroxy-3-(5-methyl-3-isoxazolylcarbamoyl)-2-methyl-2H-1,2-benzothiazine 1,1-dioxide
US5648490A (en) Process for the preparation of 5-formylaminopyrimidines
US3347864A (en) Production of aminoquinolines
US4935512A (en) Process for the preparation of quinoline-carboxylic acid derivatives